Aripiprazole: A comprehensive review of its pharmacology, clinical efficacy, and tolerability
- 1 May 2004
- journal article
- review article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 26 (5), 649-666
- https://doi.org/10.1016/s0149-2918(04)90066-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- SchizophreniaNew England Journal of Medicine, 2003
- Aripiprazole for the Prevention of Relapse in Stabilized Patients With Chronic SchizophreniaThe Journal of Clinical Psychiatry, 2003
- A Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Aripiprazole in Patients With Acute Bipolar ManiaAmerican Journal of Psychiatry, 2003
- Dopamine D2 and D3 Receptor Occupancy in Normal Humans Treated with the Antipsychotic Drug Aripiprazole (OPC 14597) A Study Using Positron Emission Tomography and [11C]RacloprideNeuropsychopharmacology, 2002
- Does Fast Dissociation From the Dopamine D2Receptor Explain the Action of Atypical Antipsychotics?: A New HypothesisAmerican Journal of Psychiatry, 2001
- Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode SchizophreniaAmerican Journal of Psychiatry, 2000
- Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) with Dopamine and Serotonin Receptor SubtypesNeuropsychopharmacology, 1999
- P.2.114 Aripiprazole, a new typical antipsychotic: Phase 2 clinical trial resultEuropean Neuropsychopharmacology, 1997
- Radioreceptor Binding Profile of the Atypical Antipsychotic OlanzapineNeuropsychopharmacology, 1996
- Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brainNeuropharmacology, 1995